Abstract:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a substantial number of deaths around the world, making it a serious and pressing public health hazard. Phytochemicals could thus provide a rich source of potent and safer anti-SARS-CoV-2 drugs. The absence of approved treatments or vaccinations continues to be an issue, forcing the creation of new medicines. Computer-aided drug design has helped to speed up the drug research and development process by decreasing costs and time. Natural compounds like terpenoids, alkaloids, polyphenols, and flavonoid derivatives have a perfect impact against viral replication and facilitate future studies in novel drug discovery. This would be more effective if collaboration took place between governments, researchers, clinicians, and traditional medicine practitioners' safe and effective therapeutic research. Through a computational approach, this study aims to contribute to the development of effective treatment methods by examining the mechanisms relating to the binding and subsequent inhibition of SARS-CoV-2 ribonucleic acid (RNA)-dependent RNA polymerase (RdRp). The in silico method has also been employed to determine the most effective drug among the mentioned compound and their aquatic, nonaquatic, and pharmacokinetics' data have been analyzed. The highest binding energy has been reported -11.4 kcal/mol against SARS-CoV-2 main protease (7MBG) in L05. Besides, all the ligands are non-carcinogenic, excluding L04, and have good water solubility and no AMES toxicity. The discovery of preclinical drug candidate molecules and the structural elucidation of pharmacological therapeutic targets have expedited both structure-based and ligand-based drug design. This review article will assist physicians and researchers in realizing the enormous potential of computer-aided drug design in the design and discovery of therapeutic molecules, and hence in the treatment of deadly diseases.

A Review on Computer‐aided Chemogenomics and Drug Repositioning for Rational COVID‐19 Drug Discovery

An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19

Recent computational drug repositioning strategies against SARS-CoV-2.

Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19

Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review

Identification of Therapeutic Drugs Against COVID-19 Through Computational Investigation on Drug Repurposing and Structural Modification

Current Status of COVID-19 Therapies and Drug Repositioning Applications

Computational Drug Design Strategies for Fighting the COVID-19 Pandemic

A Search for Medications to Treat COVID-19 Via in Silico Molecular Docking Models of the SARS-CoV-2 Spike Glycoprotein and 3CL Protease

In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

Perspective on Computer Aided Drug Discovery for Anti-Sars-cov-2

DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design

A molecular dynamics simulations analysis of repurposing drugs for COVID-19 using bioinformatics methods

COVID-19: A novel holistic systems biology approach to predict its molecular mechanisms (in vitro) and repurpose drugs

Drug Repurposing For SARS-COV-2 Using Molecular Docking

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates

Computational Drug Repositioning and Elucidation of Mechanism of Action of Compounds against SARS-CoV-2

[Drug repositioning to combat COVID-19 using artificial intelligence system]

Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference

Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics